Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1.38M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
143K
-
Shares change
-
-3.45K
-
Total reported value, excl. options
-
$623K
-
Value change
-
-$8.53K
-
Number of buys
-
3
-
Number of sells
-
-1
-
Price
-
$4.35
Significant Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q4 2019
6 filings reported holding KZIA - KAZIA THERAPEUTICS LTD - American Depository Shares as of Q4 2019.
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 143K shares
of 1.38M outstanding shares and own 10.39% of the company stock.
Largest 9 shareholders include MORGAN STANLEY (73.4K shares), RENAISSANCE TECHNOLOGIES LLC (35.9K shares), HighPoint Advisor Group LLC (32.4K shares), UBS Group AG (1.43K shares), BREWIN DOLPHIN LTD (32 shares), CITADEL ADVISORS LLC (0 shares), Transform Wealth, LLC (106K shares), Steward Partners Investment Advisory, LLC (575 shares), and DEUTSCHE BANK AG\ (300 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.